Senexin C

• Description:

  Senexin C is a novel orally active and specific CDK8/19 inhibitor with potential anticancer activity.Senexin C is more metabolically stable and potent than Senexin B. Senexin C inhibits the growth of MV4-11 leukaemia cells.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  449.55

• Molecular Formula:

  C28H27N5O

• Notes:

  Research use only, not for human use.

• Receptor:

  CDK

• CAS Number:

  2375554-02-0